InvestorsHub Logo
Followers 829
Posts 119608
Boards Moderated 14
Alias Born 09/05/2002

Re: None

Monday, 11/16/2020 5:35:22 PM

Monday, November 16, 2020 5:35:22 PM

Post# of 1162
FDA_unable_to_meet_BMY’s_liso-cell_PDUFA_date—(today)—due_to_COVID:

https://finance.yahoo.com/news/bristol-myers-squibb-provides-regulatory-212100907.html

The FDA was unable to conduct an inspection of a third-party manufacturing facility in Texas during the current review cycle due to travel restrictions related to the COVID-19 pandemic. Therefore, the FDA is deferring action on the application until the inspection can be completed. The application remains under review. The FDA did not provide a new anticipated action date.

BMY’s CELG-related CVR (#msg-145844551) is tanking again in AH trading.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BMY News